Amedeo Smart

Free Medical Literature Service



Breast Cancer

  Free Subscription

Articles published in
Cancer Cell
    May 2018
  1. CANOVAS B, Igea A, Sartori AA, Gomis RR, et al
    Targeting p38alpha Increases DNA Damage, Chromosome Instability, and the Anti-tumoral Response to Taxanes in Breast Cancer Cells.
    Cancer Cell. 2018 May 14. pii: S1535-6108(18)30181.
    >> Share

    February 2018
  2. LI CW, Lim SO, Chung EM, Kim YS, et al
    Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1.
    Cancer Cell. 2018;33:187-201.
    >> Share

  3. SALATINO M, Girotti MR, Rabinovich GA
    Glycans Pave the Way for Immunotherapy in Triple-Negative Breast Cancer.
    Cancer Cell. 2018;33:155-157.
    >> Share

  4. MCDONNELL DP, Norris JD, Chang CY
    Neomorphic ERalpha Mutations Drive Progression in Breast Cancer and Present a Challenge for New Drug Discovery.
    Cancer Cell. 2018;33:153-155.
    >> Share

  5. COSTA A, Kieffer Y, Scholer-Dahirel A, Pelon F, et al
    Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer.
    Cancer Cell. 2018 Feb 12. pii: S1535-6108(18)30011.
    >> Share

    January 2018
  6. DE MINGO PULIDO A, Gardner A, Hiebler S, Soliman H, et al
    TIM-3 Regulates CD103(+) Dendritic Cell Function and Response to Chemotherapy in Breast Cancer.
    Cancer Cell. 2018;33:60-74.
    >> Share

    November 2017
  7. PALAZON A, Tyrakis PA, Macias D, Velica P, et al
    An HIF-1alpha/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression.
    Cancer Cell. 2017;32:669-683.
    >> Share

    October 2017
  8. GULLUNI F, Martini M, De Santis MC, Campa CC, et al
    Mitotic Spindle Assembly and Genomic Stability in Breast Cancer Require PI3K-C2alpha Scaffolding Function.
    Cancer Cell. 2017;32:444-459.
    >> Share

  9. ROBERTS KJ, Kershner AM, Beachy PA
    The Stromal Niche for Epithelial Stem Cells: A Template for Regeneration and a Brake on Malignancy.
    Cancer Cell. 2017;32:404-410.
    >> Share

    August 2017
  10. YATES LR, Knappskog S, Wedge D, Farmery JHR, et al
    Genomic Evolution of Breast Cancer Metastasis and Relapse.
    Cancer Cell. 2017;32:169-184.
    >> Share

  11. ZHAO X, Powers S
    New Views into the Genetic Landscape of Metastatic Breast Cancer.
    Cancer Cell. 2017;32:131-133.
    >> Share

    April 2017
  12. HYDBRING P, Wang Y, Fassl A, Li X, et al
    Cell-Cycle-Targeting MicroRNAs as Therapeutic Tools against Refractory Cancers.
    Cancer Cell. 2017;31:576-590.
    >> Share

    October 2016
  13. SHAN L, Zhou X, Liu X, Wang Y, et al
    FOXK2 Elicits Massive Transcription Repression and Suppresses the Hypoxic Response and Breast Cancer Carcinogenesis.
    Cancer Cell. 2016 Oct 14. pii: S1535-6108(16)30445.
    >> Share

    September 2016
  14. ZENG H, Qu J, Jin N, Xu J, et al
    Feedback Activation of Leukemia Inhibitory Factor Receptor Limits Response to Histone Deacetylase Inhibitors in Breast Cancer.
    Cancer Cell. 2016;30:459-73.
    >> Share

    March 2016
  15. HALBERG N, Sengelaub CA, Navrazhina K, Molina H, et al
    PITPNC1 Recruits RAB1B to the Golgi Network to Drive Malignant Secretion.
    Cancer Cell. 2016;29:339-53.
    >> Share

  16. JING H, Hu J, He B, Negron Abril YL, et al
    A SIRT2-Selective Inhibitor Promotes c-Myc Oncoprotein Degradation and Exhibits Broad Anticancer Activity.
    Cancer Cell. 2016;29:297-310.
    >> Share

  17. GOEL S, Wang Q, Watt AC, Tolaney SM, et al
    Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors.
    Cancer Cell. 2016;29:255-69.
    >> Share

    January 2016
  18. LI JY, Perry SR, Muniz-Medina V, Wang X, et al
    A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy.
    Cancer Cell. 2016;29:117-29.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016